Benchmark Capital Advisors’s Trinity Biotech TRIB Stock Holding History

Benchmark Capital Advisors’s Portfolio TRIB Stock Details TRIB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	$39K	Sell	113 -19	-14%	-$8.8K	0.04%	110
2018 Q3	$79K	Hold	132	–	–	0.06%	129
2018 Q2	$99K	Sell	132 -21	-14%	-$15.2K	0.07%	126
2018 Q1	$118K	Sell	153 -7	-4%	-$5.73K	0.09%	125
2017 Q4	$122K	Sell	160 -93	-37%	-$71.9K	0.1%	129
2017 Q3	$213K	Sell	253 -15	-6%	-$12.6K	0.17%	116
2017 Q2	$241K	Sell	268 -2	-0.7%	-$1.7K	0.19%	106
2017 Q1	$241K	Sell	270 -47	-15%	-$44.1K	0.19%	100
2016 Q4	$329K	Sell	317 -328	-51%	-$339K	0.27%	79
2016 Q3	$1.28M	Buy	645 +38	+6%	+$71K	0.97%	36
2016 Q2	$1.03M	Buy	607 +50	+9%	+$84.5K	0.84%	40
2016 Q1	$974K	Sell	557 -35	-6%	-$55.7K	0.85%	40
2015 Q4	$1.04M	Sell	592 -8	-1%	-$14.2K	0.88%	39
2015 Q3	$1.03M	Sell	600 -16	-3%	-$38.6K	0.84%	40
2015 Q2	$1.67M	Hold	616	–	–	1.17%	30
2015 Q1	$1.78M	Buy	616 +134	+28%	+$372K	1.17%	27
2014 Q4	$1.27M	Buy	482 +8	+2%	+$20.7K	0.85%	39
2014 Q3	$1.3M	Buy	474 +94	+25%	+$305K	0.9%	37
2014 Q2	$1.31M	Hold	380	–	–	0.82%	44
2014 Q1	$1.38M	Hold	380	–	–	0.96%	36
2013 Q4	$1.43M	Hold	380	–	–	0.99%	35
2013 Q3	$1.24M	Buy	380 +36	+10%	+$105K	0.89%	38
2013 Q2	$869K	Buy	+344	New	+$856K	0.67%	48

Other funds holding TRIB

SCM

Stonehill Capital Management New York $350M AUM 73.6% 1-Year Est. Return

PIM

Paradice Investment Management Denver, Colorado $627M AUM 43.41% 1-Year Est. Return

Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return

FWSM

First Wilshire Securities Management Pasadena, California $486M AUM 50.29% 1-Year Est. Return

HAIM

Hunter Associates Investment Management Pittsburgh, Pennsylvania $868M AUM 32.25% 1-Year Est. Return

22NW LP Seattle, Washington $105M AUM 38.33% 1-Year Est. Return

Heartland Advisors Milwaukee, Wisconsin $2.25B AUM 44.61% 1-Year Est. Return

Russell Investments Group London, United Kingdom $114B AUM 41.71% 1-Year Est. Return

LAM

Lapides Asset Management Greenwich, Connecticut $153M AUM 9.03% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Benchmark Capital Advisors's TRIB Position: Q4 2018 in Review

Benchmark Capital Advisors reduced its Trinity Biotech (TRIB) stake by 14% in Q4 2018, selling an estimated $8.8K and leaving 113 shares worth $39K. The position accounts for 0.04% of the portfolio, ranked #110.

Benchmark Capital Advisors first reported a position in TRIB in Q2 2013 and has held it in 23 quarters since. The position peaked at $1.78M in Q1 2015. 40 funds tracked by Wall St. Rank hold TRIB as of Q4 2018.

Benchmark Capital Advisors held 113 shares of Trinity Biotech worth $39K as of Q4 2018.
Benchmark Capital Advisors sold 19 Trinity Biotech shares in Q4 2018, an estimated $8.8K.
Trinity Biotech made up 0.04% of Benchmark Capital Advisors's portfolio in Q4 2018, its #110 holding.
Benchmark Capital Advisors first reported a position in Trinity Biotech in Q2 2013 and has held it in 23 quarters since.
Benchmark Capital Advisors's Trinity Biotech position peaked at $1.78M in Q1 2015.
40 funds tracked by Wall St. Rank held Trinity Biotech as of Q4 2018.

Based on Benchmark Capital Advisors's 13F filing for Q4 2018, filed 11 Feb 2019.